#China #Shenzhen #AI Technology #diabetes management #SIBIONICS

SIBIONICS Celebrates the 4th AGP & DTx Summit

Recently, in Shenzhen, SIBIONICS hosted the 4th AGP & DTx Summit, an event that brought together nearly 300 professionals, clinical experts, researchers, and industry partners from across the globe to discuss the next phase of digital diabetes management. The summit operated under the theme "Beyond Glucose: The Integrated Future of CGM, CKM, and AI in Diabetes," highlighting the essential roles that Continuous Glucose Monitoring (CGM), Continuous Ketone Monitoring (CKM), digital therapies, and artificial intelligence play in the evolution of clinical practices and patient-centered care.

The forum featured over 30 international speakers including key figures like Andrej Janež, Sofianos Andrikopoulos, Shannon Lin, and Rodrigo Nunes Lamounier. Topics spanned various areas such as the clinical value and health benefits of digital therapies for diabetes, CGM-based metabolic phenotyping, and the challenges and perspectives linked to CGM technology. Attendees also engaged with discussions focused on the patient perspective towards the future of CGM and digital diabetes management, enhancing the diversity of insights presented.

In addition to the main forum, the summit included three parallel academic sessions: a clinical session, a nursing session, and a session dedicated to exemplary clinical case presentations. This initiative created a multidisciplinary platform fostering collaboration among clinical research, nursing practices, real-world application, and patient care. A central theme addressed throughout the summit was the transition from mere glucose monitoring to a more integrated and actionable approach to diabetes management.

The rise of AI-enabled tools signifies a critical shift, where CGM data is increasingly connected to daily behaviors such as diet, exercise, and medication adherence. This connection aids both users and healthcare professionals in comprehending glycemic patterns and management needs more effectively.

At the event, SIBIONICS unveiled its integrated AI capabilities within the GS3 platform. This includes tools like AI Meal Insight and AI-driven event logging designed to simplify daily recording processes, analyze the relationship between lifestyle habits and glucose fluctuations, and enhance long-term adherence to diabetes management strategies.

The summit underscored the potential of AI and digital tools to revolutionize diabetes care, making it a more personalized and proactive experience for patients. With continued advancement in technology and an emphasis on integrated management strategies, SIBIONICS is positioning itself at the forefront of a transformational shift in the diabetes management landscape, fostering better health outcomes through innovation.

Conclusion

As healthcare continues to evolve with the integration of artificial intelligence and digital therapies, SIBIONICS stands at the leading edge, championing an era where diabetes management is not just reactive but also predictive and personalized. The success of the AGP & DTx Summit is a testament to the collaborative efforts between industry stakeholders to pave the way toward more effective diabetes care, ultimately benefiting millions of patients worldwide.